Updated:
Innovaccer
Innovaccer sells an AI data platform to Kaiser, Banner Health, and CommonSpirit, unifying clinical and claims data for value-based care.
Innovaccer
Innovaccer sells to health systems and payers as a pure software company, not a care provider. Its stack — branded the Agentic Cloud for Healthcare — sits on top of existing electronic health records and claims systems, normalizing data into a unified patient record. The company was backed by institutional venture investors before its growth-stage rounds; exact founding details are undisclosed, though its engineering center has long operated from Noida, India. The platform covers at least five product lines. Gravity handles population health and value-based contracts; Flow automates end-to-end revenue cycle; Galaxy runs payer risk and quality analytics; Cured adds AI-driven healthcare marketing; and Comet powers access-center operations. Confirmed deployments include Banner Health (1.4 million value-based lives, per the firm, 2025), CommonSpirit Health (all-payer value-based claims solution), and Kaiser Permanente Washington, where Innovaccer’s value-based care AI went live statewide. The firm also acquired Cured in 2024 to add healthcare CRM and patient-engagement software. Geographic concentration is North America, with no disclosed international provider customers. Team size and total capital raised are not publicly disclosed. The firm operates an AI center of excellence and publishes case studies on 340B optimization, payment integrity, and Medicare Advantage star-rating improvement. In the current cycle, CEO Abhinav Shashank signed a letter positioning the company’s mission around bringing “joy to healthcare,” signaling consumer-grade experience ambitions. Recent operational moves include the Kaiser Permanente Washington statewide deployment and the Cured acquisition. What distinguishes Innovaccer structurally is its agentic-AI posture embedded into an existing data-activation layer. Instead of replacing EHRs, it connects to them, ingests payer claims feeds, and builds a real-time underlying patient record that feeds copilots, scheduling bots, and prior-auth engines. This positions it as horizontal infrastructure across clinical, financial, and operational workflows — a different bet than vertical point-solution AI tools sold to a single department.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
Who runs product and engineering decisions at Innovaccer?
Innovaccer does not publicly name its C-suite or board. The CEO's letter on the company's about page is signed by Abhinav Shashank, and the firm's engineering base has historically operated from Noida, India. The absence of a publicly listed executive team makes it difficult for an allocator to assess leadership depth without a direct reference call.
Is Innovaccer a services firm or a product company?
It is a product company. All revenue comes from its cloud platform, which integrates with existing EHRs and payer claims feeds. The firm's case studies show Orlando Health, CHI Health, and UCHealth using the software directly via dashboards and copilot interfaces, not through a managed-services wrapper. Deployment is measured in covered lives and provider logins, not billable hours.
How does Innovaccer get its data — does it compete with Epic or Cerner?
No. Innovaccer sits on top of existing EHRs, pulling data via APIs and HL7 feeds, then normalizing it into a unified patient record. It also ingests payer claims files for risk and quality analytics. The firm's own labeling — 'Healthcare Intelligence Cloud' — and its KLAS-recognized point-of-care solution InNote position it as an augmentation layer, not a system-of-record replacement.
Does the firm have any known regulatory risk or government contracting exposure?
Innovaccer does not disclose government contracts, but its platform supports activities that touch CMS-regulated programs: Medicare Advantage star ratings, 340B drug pricing optimization, and Medicaid analytics. Any change to CMS value-based-care reimbursement models would directly affect the economic case its health-system customers make for buying the platform.
What investment stage or institutional backing does Innovaccer have today?
The company has raised institutional capital across multiple rounds, though exact amounts and lead investors are not confirmed in currently available sources. Its website displays logos of backing institutions without naming them or the round dates. No public filing or press release on this record provides a verifiable capital-raising history.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: